Pulmonary Arterial Hypertension Expert Column

The Importance of Early Diagnosis and Treatment of PAH Early recognition and treatment of PAH may be the key to target the disease before the right ventricle becomes affected for the best durable long-term outcome.
Experts And Viewpoints, March 26, 2009
The EARLY Trial In PAH The EARLY study is the first randomized, double-blind, multicenter, placebo-controlled clinical trial to study the role of endothelin receptor antagonism on disease progression in early-stage PAH.
Experts And Viewpoints, July 31, 2008
Combination Therapy for PAH Dr. Myung Park reviews the current status and future direction of combination therapy for pulmonary arterial hypertension.
Experts And Viewpoints, June 25, 2008
Pulmonary Hypertension in Heart Failure A review of the current data on treatment options and management of pulmonary hypertension in heart failure.
Experts And Viewpoints, March 10, 2008
Sarcoidosis and Pulmonary Hypertension A review of the current data on sarcoidosis and pulmonary hypertension.
Experts And Viewpoints, February 14, 2008
Improving Outcomes Through Early Intervention Most of the pivotal PAH trials have focused on functional class III/IV patients. Recent studies have included class I/ II patients, suggesting that early treatment of these groups may be beneficial.
Experts And Viewpoints, December 12, 2007
New Insights Into the Pathobiology of Pulmonary Hypertension in COPD New insights into the pathobiology of PH in COPD reveal that endothelial dysfunction with impairment of synthesis and release of endothelium-derived mediators play a fundamental role in pathogenesis.
Experts And Viewpoints, November 07, 2007
Chronic Thromboembolic Pulmonary Hypertension An update on the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (CTEPH).
Experts And Viewpoints, May 17, 2007
Pulmonary Hypertension in Congenital Heart Disease An update on the diagnosis and treatment of Eisenmenger's syndrome.
Experts And Viewpoints, February 13, 2007
Portopulmonary Hypertension A review of the diagnosis and treatment of portopulmonary hypertension.
Experts And Viewpoints, December 19, 2006
An Expert Interview With Mark Gladwin, MD -- Part 1: HIV and PAH The links between pulmonary arterial hypertension, HIV, and sickle cell disease remain unclear. The NIH's Mark Gladwin, MD, discussed what we do know about the interactions of these conditions.
Experts And Viewpoints, September 27, 2006
An Expert Interview With Mark Gladwin, MD -- Part 2: PAH and Sickle Cell The incidence of PAH in patients with sickle cell disease may be as high as 32%. In Part 2 of our interview, Mark Gladwin, MD, Chief, Vascular Medical Branch, NHLBI, NIH, discusses this disease.
Experts And Viewpoints, September 27, 2006
IPF and PAH: An Expert Interview With Steven Nathan, MD Steven Nathan, MD, Director, Lung Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia, discusses the relationship between IPF and PAH.
Experts And Viewpoints, June 08, 2006
Role of CCBs in Pulmonary Arterial Hypertension Calcium channel blockers (CCBs) have been used in the treatment of pulmonary arterial hypertension (PAH) for over 25 years.
Experts And Viewpoints, February 23, 2006
Combination Therapy: The Future of Medical Management for PAH Current treatment strategy for PAH targets the mediators of the 3 main biologic pathways that are critical to its pathogenesis and progression. This review looks at the role of combination therapy.
Experts And Viewpoints, October 18, 2005
Therapeutic Options for the Treatment of Pulmonary Hypertension An overview of treatment strategies for pulmonary arterial hypertension.
Experts And Viewpoints, September 07, 2005
The Role of Endothelins in Sickle Cell Disease A review of endothelins in SCD, in particular as they relate to PAH.
Experts And Viewpoints, July 28, 2005
The Role of Endothelin in the Pathogenesis of Systemic Sclerosis An in-depth look at the potential role of ET-1 in SSc pathogenesis.
Experts And Viewpoints, July 28, 2005
Early Diagnosis and Treatment of Pulmonary Arterial Hypertension An overview of diagnosis and treatment strategies for pulmonary arterial hypertension
Experts And Viewpoints, June 29, 2005
Scleroderma and Pulmonary Arterial Hypertension Scleroderma is an autoimmune disease afflicting the skin and viscera. Two experts discuss its prevalence, prognosis, issues surrounding diagnosis, and management of scleroderma-associated PAH.
Experts And Viewpoints, April 04, 2005

No Results